Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopia Using Optical Coherence Tomography Angiography (OCTA) And Visual Evoked Potential (VEP). The Aim Of The Study Is To Evaluate Possible Beneficial Effects For Different Age Groups. [NA]

View source ↗

Summary

A clinical trial is investigating whether combining fluoxetine with occlusion therapy can improve vision in amblyopia and maintain gains across different age gr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: Minia University | Conditions: Amblyopia, VEP | NA | Status: RECRUITING